Fascinating article from the folks at NEUROTECH FUTURES, who recently sat down with Dr. Benjamin Rapoport to learn about his work as co-founder of Precision Neuroscience and his perspective on several emergent topics in BCI commercialization. Ben discusses his time at Elon Musk’s Neuralink, the reasons he left, and how those reasons became the foundation for a new brain-computer interface company, Precision Neuroscience. The article also addresses the clinical practice guidelines for brain-computer interfaces, explantation (a topic nobody in BCI talks about), and the referral pathways that will inform the patient’s journey to getting a BCI in the near future. Read the full article below for more... #Neurotech #BrainComputerInterface #BrainTumorSurgery #BrainSurgery #Neurosurgery #Neurosurgeon
Precision Neuroscience
Medical Equipment Manufacturing
Manhattan, NY 16,383 followers
About us
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from neurological illnesses. We are building the only brain–computer interface that is designed to be minimally invasive, safely removable, and capable of processing large amounts of data. To learn more about how Precision is connecting human intelligence and artificial intelligence, visit www.precisionneuro.io.
- Website
-
http://precisionneuro.io
External link for Precision Neuroscience
- Industry
- Medical Equipment Manufacturing
- Company size
- 11-50 employees
- Headquarters
- Manhattan, NY
- Type
- Privately Held
- Specialties
- brain-computer interfaces, medical device, neuroscience, neurology, and BCI
Locations
-
Primary
Manhattan, NY 10010, US
-
Mountain View, CA, US
-
Bloomington, MN, US
Employees at Precision Neuroscience
-
Ludwig Pierre Schulze
Managing Partner @ Alumni Ventures
-
Gabe Greenbaum
General Partner @ B Capital Group | MBA, JD | Early and Growth Stage Venture Capital
-
Joe Sharron
The Team at Precision -Ex Neuralink -C3/C4 SCI -Inspiring people of all abilities- Ex HubSpot
-
Craig Mermel
President and Chief Product Officer @ Precision Neuroscience
Updates
-
I have the honor of announcing Dr. Craig Mermel, President and Chief Product Officer at Precision Neuroscience, as our next speaker in our conference series. Dr. Mermel earned his MD/PhD from Harvard University and is a seasoned expert in cancer genomics and pathology. Simbionics, a digital health company he co-founded with Dr. Benjamin Rapoport was later acquired by Apple where he was instrumental in the early development of biosensors. He then spearheaded AI computer vision application to medical imaging data at Google Health. When I met with Dr. Mermel, I was inspired by the multidisciplinary nature of his career, making his impact in billion dollar companies of Apple and Google along the way and now in BCI at Precision Neuroscience. I would like to extend a warm welcome to Dr. Craig Mermel and I look forward to working collaboratively with him in the BCI and oncology spaces. - Neilank K. Jha, MD, FRCS(C), MSc, MBA, Conference Chair
-
-
It is an honor to announce our newest speaker for the NeuraSeed BCI Expo 2024, Jayme Strauss RN,MSN,MBA,SCRN, and congratulate her on her newest role as Chief Commercial and Clinical Officer at Precision Neuroscience. Jayme’s background is as a seasoned ICU nurse where she provided direct care to a variety of patients including those on trauma, neurology, and burn units. She then gained over a decade of experience leading programs in a variety of medical specialties with a particular commitment to stroke management. She also served as Executive Director of Neurosciences at Piedmont Healthcare, a network of over 11 hospitals. As former Chief Clinical Officer at Viz.ai, she spearheaded AI solutions that revolutionize the diagnosis and treatment of neurological conditions across a variety of markets. When I met Jayme, learning about her personal and professional journey has been a great inspiration. Her insights range from the true day-to-day patient experience to global innovations in healthcare. She is incredibly passionate about making a positive impact on the lives of patients and their families. NeuraSeed BCI is incredibly fortunate to have Jayme share her journey and insights. - Neilank K. Jha, MD, FRCS(C), MSc, MBA, Conference Chair
-
-
We are excited to announce two more additions to the Precision Neuroscience leadership team. Jayme Strauss RN,MSN,MBA,SCRN has joined the company as Chief Clinical and Commercial Officer, and Mike Kaswan has joined as Chief Financial Officer. Jayme and Mike will apply their decades of experience in healthcare innovation to accelerate Precision's mission to deliver on the promise of neurotechnology to transform brain health! Read the full news release below.
Precision Neuroscience Expands Executive Team as Brain–Computer Interface Industry Rapidly Advances
globenewswire.com
-
Precision Neuroscience / Precision BioMEMS will be part of the "BCI: State of the Art, Art of the Future" panel discussion this week at the IEEE Engineering Medicine and Biology Society 2024 conference, the world’s largest international biomedical engineering conference, currently underway in Orlando. Stop by the panel session on July 18th, for what promises to be a lively and informative discussion on brain-computer interfaces and their implications for the future of healthcare. #EMBC2024
-
-
Precision BioMEMS / Precision Neuroscience are proud to be an official sponsor of the 46th Annual International Conference of the IEEE Engineering Medicine and Biology Society, taking place in Orlando, July 15 - 19, 2024. Precision is honored to support IEEE’s vision for the 2024 conference: “Technology and its promise for equity and access for well-health,” which will address the positive impacts that engineering can have on the whole of society. The conference will cover a broad array of scientific tracks, from cutting-edge research in biomedical engineering to healthcare technology, in particular for women and children’s health. Stop by the Precision booth at IEEE EMBC 2024 to learn about Precision BioMEMS, our wholly owned and operated MEMS facility that produces our biocompatible microelectrode arrays and offers foundry services to pioneering third-party companies.
-
-
Join Precision Neuroscience’s Head of Microfabrication, Mark Hettick, today at the FLEX / SEMICON WEST 2024 Precision BioMEMS FLEXTalks presentation: “BioMEMS and FLEX Electronics: Medical FLEX Applications and a Foundry to Serve Them”. The topics among Mark’s talk will include the explosion of neurotech and the growing field of implantable MEMS, applications of flexible electronics, and new BioMEMS structures that are becoming increasingly relevant. Tuesday, July 9th, 2.20pm - 2.35pm at the Smart Stage FLEX Theater in the South Expo Hall (by the FLEX Exhibits) #SEMICONWest #SEMI_FLEX #BioMEMS #MicroFluidics #MedicalMEMS
-
-
Heading to SEMI Americas SEMICON WEST / FLEX 2024 conference this week in San Francisco? Stop by the Precision BioMEMS booth to learn firsthand about Precision's world class in-house manufacturing, foundry services, customized microfluidic platforms, and how Precision BioMEMS is shaping the future of Medical MEMS. Booth 1859 in the SEMICON WEST / FLEX South Expo Hall. #SEMICONWest #SEMI_FLEX
-
-
I am proud to announce Dr. Benjamin Rapoport, Co-Founder and Chief Science Officer of Precision Neuroscience, as our next speaker in our conference series. Dr. Rapoport co-founded Neuralink with Elon Musk; he not only obtained his MD from Harvard Medical School Department of Biomedical Informatics and pursued a residency in Neurosurgery, but has his Master's in Mathematics from University of Oxford and PhD in Electrical Engineering and Computer Science from the Massachusetts Institute of Technology. Our team met with Dr. Rapoport's team several months ago and they shared our excitement in having Dr. Rapoport present his insights and groundbreaking work at the Expo. We're fortunate to have someone with his pedigree and knowledge participate at our conference. - Neilank K. Jha, MD, FRCS(C), MSc, MBA, Conference Chair
-
-
“Think about the idea of planting a device that can change the outcome of diseases like ALS, stroke, traumatic brain injury—so many things that we think are previously utterly untreatable...” - Kenneth L. Davis, MD, Executive Vice Chair, Board of Trustees, Mount Sinai Health System, introducing a panel at the Aspen Ideas Festival on the “Brain–Computer Interface Revolution.” Much of that revolution is taking place at Mount Sinai in New York City, where both Precision Neuroscience’s Benjamin Rapoport and Synchron’s Thomas Oxley are members of a groundbreaking neurosurgery department led by Dr. Joshua Bederson. Watch the video below for stories and insights from the front lines. #BrainComputerInterface #Neurosurgery #Neuroscience #AspenIdeas
Mount Sinai Presents: Brain-Computer Interface Revolution | Aspen Ideas
aspenideas.org